查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555638

經導管主動脈瓣置換市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Transcatheter Aortic Valve Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 175 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球經導管主動脈瓣置換術（TAVR）市場的綜合報告，深入分析了主要市場動態，包括驅動因素、機會、挑戰和趨勢。本報告提供了有關市場結構和未來前景的寶貴見解。

主要見解

  • 經導管主動脈瓣置換術市場規模（2024年）：56.4億美元
  • 預測市值（2031年）：105億美元
  • 全球市場成長率（2024-2031年年複合成長率）：6.5%

經導管主動脈瓣置換市場-調查範圍：

TAVR 市場致力於基於經導管的手術，用於更換受損的主動脈瓣，特別是對於傳統心臟直視手術處於高或中風險的患者。由於閥門技術和微創技術的進步，該市場迅速擴大。由於人口老化和心血管疾病盛行率上升，世界各地的醫院、心臟中心和診所日益採用 TAVR 手術。

市場驅動因素：

全球 TAVR 市場主要是由 TAVR 手術適應症的擴大所推動的，特別是對於低風險患者。靈活、先進的輸送系統的發展使移植手術變得更加順利和安全。閥門材料的持續技術創新和閥門耐用性的提高進一步推動市場成長。此外，人口老化的加劇和主動脈瓣狹窄的高盛行率導致對 TAVR 手術的需求不斷成長。

市場限制因素：

儘管 TAVR 市場呈現出良好的成長形勢，但仍有一些挑戰阻礙其充分發揮潛力。 TAVR 設備和手術的高成本，加上複雜的監管環境，尤其是在新興市場，是主要障礙。此外，某些地區缺乏熟練的專業人員來執行這些高度專業化的程序，限制了更廣泛的市場採用。對低風險患者瓣膜長期耐用性的擔憂也為市場擴張帶來了挑戰。

市場機會：

TAVR 市場提供了巨大的成長機會，特別是在醫療保健現代化不斷發展的新興市場。在亞太地區等地區，醫療保健成本的上升和先進治療方法的改善為市場進入者創造有利的機會。此外，老年族群對微創治療意識的增強以及對非手術選擇的日益偏好推動對 TAVR 手術的需求。

本報告涵蓋的主要問題

  • 推動全球 TAVR 市場的主要因素是什麼？
  • 市場在不同醫療保健環境中的擴張情況如何？
  • 哪些技術創新塑造 TAVR 手術的未來？
  • 採用什麼策略來維持市場競爭力？
  • 全球 TAVR 市場有哪些新趨勢？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 經導管主動脈瓣置換術採用/使用分析：依地區
  • PESTLE分析
  • 各地區的主要法規
  • 波特五力分析
  • 宏觀經濟因素
    • 世界產業展望
    • 世界 GDP 成長前景
    • 世界母市場概覽

第3章 2019-2023年價格趨勢分析

  • 主要亮點
  • 影響治療費用的主要因素
  • 依治療收費
  • 區域定價和說明

第4章 全球經導管主動脈瓣置換市場展望：過去（2019-2023年）與預測（2024-2031年）

  • 主要亮點
    • 市場價值（十億美元）預測
    • 市場規模及年成長率
    • 絕對的獲利機會
  • 市場規模分析與預測（十億美元）
    • 過去的市場規模分析，2019-2023年
    • 目前市場規模預測，2023-2031年
  • 全球經導管主動脈瓣置換市場展望：程序
    • 簡介/主要調查結果
    • 2019-2023年市場規模（價值與數量）分析
    • 2024-2031年市場規模（價值與數量）預測
      • 經股骨植入物
      • 經心尖植體
      • 經主動脈植入物
  • 市場吸引力分析：技術
  • 全球經導管主動脈瓣置換市場展望：機制
    • 簡介/主要調查結果
    • 2019-2023年市場規模（金額）分析
    • 2024-2031年市場規模（金額）預測
      • 自我擴張
      • 氣球可膨脹
  • 市場吸引力分析：機制
  • 全球經導管主動脈瓣置換市場展望：最終應用
    • 簡介/主要調查結果
    • 2019-2023年市場規模（金額）分析
    • 2024-2031年市場規模（金額）預測
      • 醫院
      • 門診手術中心
      • 其他
  • 市場吸引力分析：最終用途

第5章 全球經導管主動脈瓣置換市場展望：地區

  • 主要亮點
  • 2019-2023年市場規模（金額）分析
  • 2024-2031年市場規模（金額）預測
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第6章 北美經導管主動脈瓣置換市場展望：過去（2019-2023年）與預測（2024-2031年）

第7章 歐洲經導管主動脈瓣置換市場展望：過去（2019-2023年）與預測（2024-2031年）

第8章 亞太地區經導管主動脈瓣置換市場展望：歷史（2019-2023年）與預測（2024-2031年）

第9章 拉丁美洲經導管主動脈瓣置換市場展望：歷史（2019-2023年）與預測（2024-2031年）

第10章 中東和非洲經導管主動脈瓣置換市場展望：歷史（2019-2023年）和預測（2024-2031年）

第11章 競爭態勢

  • 2023年市佔率分析
  • 市場結構
    • 依市場劃分的競爭強度圖
    • 競爭儀表板
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Boston Scientific Corporation
    • Medtronic Plc
    • Abbott Laboratories
    • Anteris Technologies Ltd.
    • Coroneo Inc.
    • CryoLife Inc.
    • Edward Lifesciences Corporation
    • JenaValve Technology Inc.
    • LifeNet Health Inc.
    • LivaNova PLC
    • Thubrikar Aortic Valve Inc.

第12章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34740

Persistence Market Research has recently published a comprehensive report on the global Transcatheter Aortic Valve Replacement (TAVR) Market, offering an in-depth analysis of key market dynamics such as drivers, opportunities, challenges, and trends. The report provides valuable insights into the structure and future prospects of the market.

Key Insights:

  • Transcatheter Aortic Valve Replacement Market Size (2024E): USD 5.64 Bn
  • Projected Market Value (2031F): USD 10.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.5%

Transcatheter Aortic Valve Replacement Market - Report Scope:

The TAVR market focuses on the transcatheter-based procedure for replacing damaged aortic valves, particularly for patients who are at high or intermediate risk during traditional open-heart surgeries. This market is expanding rapidly due to advancements in valve technology and minimally invasive techniques. The increased adoption of TAVR procedures is being witnessed in hospitals, specialized cardiac centers, and clinics worldwide, driven by the aging population and the rising prevalence of cardiovascular diseases.

Market Growth Drivers:

The global TAVR market is primarily driven by the expanding indications for TAVR procedures, particularly for low-risk patients. The development of flexible and advanced delivery systems has enabled smoother and safer implantation procedures. Continuous innovation in valve materials and enhancements in valve durability are further supporting market growth. Additionally, the increasing aging population and the high prevalence of aortic stenosis contribute to the growing demand for TAVR procedures.

Market Restraints:

While the TAVR market shows promising growth, several challenges impede its full potential. High costs of TAVR devices and procedures, coupled with the complex regulatory landscape, particularly in emerging markets, present significant barriers. Additionally, a lack of skilled professionals in certain regions to perform these highly specialized procedures limits broader market adoption. Concerns over long-term valve durability in low-risk patients also pose challenges to market expansion.

Market Opportunities:

The TAVR market offers significant growth opportunities, especially in emerging markets with ongoing healthcare modernization efforts. Increasing healthcare expenditure and improving access to advanced treatments in regions like Asia-Pacific are creating lucrative opportunities for market players. Additionally, growing awareness of minimally invasive treatments and the rising preference for non-surgical options among the elderly population are boosting demand for TAVR procedures.

Key Questions Answered in the Report:

  • What are the key factors driving the TAVR market globally?
  • How is the market expanding in different healthcare settings?
  • Which technological innovations are shaping the future of TAVR procedures?
  • Who are the leading players in the market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market are investing in research and development (R&D) to innovate advanced valve systems and delivery platforms. Companies are focusing on strategic partnerships with hospitals and specialized cardiac centers to increase the adoption of TAVR procedures. Significant emphasis is placed on consumer education and regulatory approvals, which play a critical role in the competitive landscape.

Key Market Players

  • Boston Scientific Corporation
  • Medtronic Plc
  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Coroneo Inc.
  • CryoLife Inc.
  • Edward Lifesciences Corporation
  • JenaValve Technology Inc.
  • LifeNet Health Inc.
  • LivaNova PLC
  • Thubrikar Aortic Valve Inc.

Transcatheter Aortic Valve Replacement Market Segmentation

By Procedure

  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation

By Mechanism

  • Self-Expanding
  • Balloon-expandable

By End User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Transcatheter Aortic Valve Replacement Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Transcatheter Aortic Valve Replacement Adoption / Usage Analysis, By Region
  • 2.4. PESTLE Analysis
  • 2.5. Key Regulations by Region
  • 2.6. Porter Five Force's Analysis
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview

3. Price Trend Analysis, 2019-2031

  • 3.1. Key Highlights
  • 3.2. Key Factors Impacting Procedure Prices
  • 3.3. Prices By Procedure
  • 3.4. Regional Prices and Procedure Preferences

4. Global Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Value (US$ in Bn) Projections
    • 4.1.2. Market Size and Y-o-Y Growth
    • 4.1.3. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Transcatheter Aortic Valve Replacement Market Outlook: Procedure
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) and Volume (Units) and Analysis by Procedure, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
      • 4.3.3.1. Transfemoral Implantation
      • 4.3.3.2. Transapical Implantation
      • 4.3.3.3. Transaortic Implantation
  • 4.4. Market Attractiveness Analysis: Procedure
  • 4.5. Global Transcatheter Aortic Valve Replacement Market Outlook: Mechanism
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis by Mechanism, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
      • 4.5.3.1. Self-Expanding
      • 4.5.3.2. Balloon-Expandable
  • 4.6. Market Attractiveness Analysis: Mechanism
  • 4.7. Global Transcatheter Aortic Valve Replacement Market Outlook: End-use
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2023
    • 4.7.3. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
      • 4.7.3.1. Hospital
      • 4.7.3.2. Ambulatory Surgical Centers
      • 4.7.3.3. Others
  • 4.8. Market Attractiveness Analysis: End-use

5. Global Transcatheter Aortic Valve Replacement Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Forecast by Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Procedure
    • 6.2.3. By Mechanism
    • 6.2.4. By End-use
  • 6.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 6.4.1. Transfemoral Implantation
    • 6.4.2. Transapical Implantation
    • 6.4.3. Transaortic Implantation
  • 6.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 6.5.1. Self-Expanding
    • 6.5.2. Balloon-expandable
  • 6.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 6.6.1. Hospital
    • 6.6.2. Ambulatory Surgical Centers
    • 6.6.3. Dental Clinics
  • 6.7. Market Attractiveness Analysis

7. Europe Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Procedure
    • 7.2.3. By Mechanism
    • 7.2.4. By End-use
  • 7.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. Italy
    • 7.3.3. France
    • 7.3.4. U.K.
    • 7.3.5. Turkey
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 7.4.1. Transfemoral Implantation
    • 7.4.2. Transapical Implantation
    • 7.4.3. Transaortic Implantation
  • 7.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 7.5.1. Self-Expanding
    • 7.5.2. Balloon-expandable
  • 7.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 7.6.1. Hospital
    • 7.6.2. Ambulatory Surgical Centers
    • 7.6.3. Dental Clinics
  • 7.7. Market Attractiveness Analysis

8. Asia Pacific Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Procedure
    • 8.2.3. By Mechanism
    • 8.2.4. By End-use
  • 8.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
    • 8.3.4. India
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 8.4.1. Transfemoral Implantation
    • 8.4.2. Transapical Implantation
    • 8.4.3. Transaortic Implantation
  • 8.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 8.5.1. Self-Expanding
    • 8.5.2. Balloon-expandable
  • 8.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 8.6.1. Hospital
    • 8.6.2. Ambulatory Surgical Centers
    • 8.6.3. Dental Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Procedure
    • 9.2.3. By Mechanism
    • 9.2.4. By End-use
  • 9.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Argentina
    • 9.3.4. Rest of Latin America
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 9.4.1. Transfemoral Implantation
    • 9.4.2. Transapical Implantation
    • 9.4.3. Transaortic Implantation
  • 9.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 9.5.1. Self-Expanding
    • 9.5.2. Balloon-expandable
  • 9.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 9.6.1. Hospital
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Dental Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Procedure
    • 10.2.3. By Mechanism
    • 10.2.4. By End-use
  • 10.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Egypt
    • 10.3.4. Nigeria
    • 10.3.5. Rest of Middle East and Africa
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
    • 10.4.1. Transfemoral Implantation
    • 10.4.2. Transapical Implantation
    • 10.4.3. Transaortic Implantation
  • 10.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
    • 10.5.1. Self-Expanding
    • 10.5.2. Balloon-expandable
  • 10.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
    • 10.6.1. Hospital
    • 10.6.2. Ambulatory Surgical Centers
    • 10.6.3. Dental Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping by Market
    • 11.2.2. Competition Dashboard
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Boston Scientific Corporation
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Medtronic Plc
    • 11.3.3. Abbott Laboratories
    • 11.3.4. Anteris Technologies Ltd.
    • 11.3.5. Coroneo Inc.
    • 11.3.6. CryoLife Inc.
    • 11.3.7. Edward Lifesciences Corporation
    • 11.3.8. JenaValve Technology Inc.
    • 11.3.9. LifeNet Health Inc.
    • 11.3.10. LivaNova PLC
    • 11.3.11. Thubrikar Aortic Valve Inc.

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations